Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Related structures:
AlphaFold database: Q4Q8T5
Term | Name | Level | Count |
---|---|---|---|
GO:0008152 | metabolic process | 1 | 2 |
GO:0032259 | methylation | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 16 |
GO:0003824 | catalytic activity | 1 | 19 |
GO:0005488 | binding | 1 | 16 |
GO:0005524 | ATP binding | 5 | 16 |
GO:0008716 | D-alanine-D-alanine ligase activity | 5 | 16 |
GO:0016740 | transferase activity | 2 | 16 |
GO:0016874 | ligase activity | 2 | 16 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 3 | 16 |
GO:0016881 | acid-amino acid ligase activity | 4 | 16 |
GO:0017076 | purine nucleotide binding | 4 | 16 |
GO:0030554 | adenyl nucleotide binding | 5 | 16 |
GO:0032553 | ribonucleotide binding | 3 | 16 |
GO:0032555 | purine ribonucleotide binding | 4 | 16 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 16 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 16 |
GO:0036094 | small molecule binding | 2 | 16 |
GO:0043167 | ion binding | 2 | 16 |
GO:0043168 | anion binding | 3 | 16 |
GO:0043169 | cation binding | 3 | 16 |
GO:0046872 | metal ion binding | 4 | 16 |
GO:0097159 | organic cyclic compound binding | 2 | 16 |
GO:0097367 | carbohydrate derivative binding | 2 | 16 |
GO:1901265 | nucleoside phosphate binding | 3 | 16 |
GO:1901363 | heterocyclic compound binding | 2 | 16 |
GO:0008168 | methyltransferase activity | 4 | 2 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 19 | 23 | PF00656 | 0.477 |
CLV_C14_Caspase3-7 | 488 | 492 | PF00656 | 0.674 |
CLV_NRD_NRD_1 | 349 | 351 | PF00675 | 0.519 |
CLV_PCSK_KEX2_1 | 269 | 271 | PF00082 | 0.361 |
CLV_PCSK_KEX2_1 | 349 | 351 | PF00082 | 0.491 |
CLV_PCSK_PC1ET2_1 | 269 | 271 | PF00082 | 0.361 |
CLV_PCSK_PC7_1 | 265 | 271 | PF00082 | 0.361 |
CLV_PCSK_SKI1_1 | 265 | 269 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 291 | 295 | PF00082 | 0.336 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.440 |
DEG_APCC_DBOX_1 | 341 | 349 | PF00400 | 0.529 |
DOC_CKS1_1 | 33 | 38 | PF01111 | 0.426 |
DOC_CYCLIN_yCln2_LP_2 | 5 | 11 | PF00134 | 0.509 |
DOC_MAPK_gen_1 | 286 | 295 | PF00069 | 0.470 |
DOC_MAPK_gen_1 | 339 | 348 | PF00069 | 0.414 |
DOC_MAPK_MEF2A_6 | 217 | 226 | PF00069 | 0.491 |
DOC_MAPK_MEF2A_6 | 288 | 297 | PF00069 | 0.542 |
DOC_MAPK_MEF2A_6 | 496 | 505 | PF00069 | 0.549 |
DOC_MAPK_MEF2A_6 | 506 | 513 | PF00069 | 0.475 |
DOC_PP1_RVXF_1 | 289 | 295 | PF00149 | 0.517 |
DOC_PP4_FxxP_1 | 483 | 486 | PF00568 | 0.533 |
DOC_PP4_FxxP_1 | 99 | 102 | PF00568 | 0.440 |
DOC_USP7_MATH_1 | 432 | 436 | PF00917 | 0.511 |
DOC_USP7_MATH_1 | 438 | 442 | PF00917 | 0.470 |
DOC_USP7_UBL2_3 | 115 | 119 | PF12436 | 0.386 |
DOC_WW_Pin1_4 | 32 | 37 | PF00397 | 0.426 |
DOC_WW_Pin1_4 | 482 | 487 | PF00397 | 0.516 |
DOC_WW_Pin1_4 | 489 | 494 | PF00397 | 0.583 |
LIG_Actin_WH2_2 | 435 | 450 | PF00022 | 0.479 |
LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.475 |
LIG_EH1_1 | 171 | 179 | PF00400 | 0.561 |
LIG_eIF4E_1 | 172 | 178 | PF01652 | 0.458 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.418 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.501 |
LIG_FHA_1 | 492 | 498 | PF00498 | 0.636 |
LIG_FHA_1 | 500 | 506 | PF00498 | 0.676 |
LIG_FHA_2 | 209 | 215 | PF00498 | 0.538 |
LIG_LIR_Apic_2 | 481 | 486 | PF02991 | 0.541 |
LIG_LIR_Apic_2 | 97 | 102 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 129 | 137 | PF02991 | 0.349 |
LIG_LIR_Gen_1 | 158 | 165 | PF02991 | 0.479 |
LIG_LIR_Gen_1 | 187 | 197 | PF02991 | 0.561 |
LIG_LIR_Gen_1 | 327 | 336 | PF02991 | 0.393 |
LIG_LIR_Gen_1 | 395 | 403 | PF02991 | 0.511 |
LIG_LIR_Gen_1 | 69 | 76 | PF02991 | 0.408 |
LIG_LIR_Nem_3 | 129 | 135 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 147 | 153 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 158 | 163 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 187 | 193 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 230 | 235 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 327 | 331 | PF02991 | 0.389 |
LIG_LIR_Nem_3 | 395 | 399 | PF02991 | 0.508 |
LIG_LIR_Nem_3 | 409 | 415 | PF02991 | 0.466 |
LIG_LIR_Nem_3 | 457 | 463 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.388 |
LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.387 |
LIG_MAD2 | 291 | 299 | PF02301 | 0.533 |
LIG_Pex14_2 | 235 | 239 | PF04695 | 0.477 |
LIG_SH2_CRK | 160 | 164 | PF00017 | 0.484 |
LIG_SH2_CRK | 60 | 64 | PF00017 | 0.407 |
LIG_SH2_GRB2like | 124 | 127 | PF00017 | 0.480 |
LIG_SH2_NCK_1 | 125 | 129 | PF00017 | 0.466 |
LIG_SH2_NCK_1 | 160 | 164 | PF00017 | 0.484 |
LIG_SH2_PTP2 | 132 | 135 | PF00017 | 0.458 |
LIG_SH2_STAT3 | 386 | 389 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.455 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.507 |
LIG_SH2_STAT5 | 347 | 350 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 396 | 399 | PF00017 | 0.523 |
LIG_SH3_3 | 131 | 137 | PF00018 | 0.532 |
LIG_SH3_3 | 215 | 221 | PF00018 | 0.478 |
LIG_SH3_3 | 487 | 493 | PF00018 | 0.529 |
LIG_SH3_4 | 115 | 122 | PF00018 | 0.406 |
LIG_SUMO_SIM_anti_2 | 441 | 446 | PF11976 | 0.532 |
LIG_TRAF2_1 | 95 | 98 | PF00917 | 0.448 |
LIG_TYR_ITIM | 275 | 280 | PF00017 | 0.492 |
LIG_TYR_ITSM | 56 | 63 | PF00017 | 0.437 |
MOD_CDK_SPxxK_3 | 489 | 496 | PF00069 | 0.615 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.503 |
MOD_CK1_1 | 208 | 214 | PF00069 | 0.555 |
MOD_CK1_1 | 366 | 372 | PF00069 | 0.511 |
MOD_CK1_1 | 485 | 491 | PF00069 | 0.596 |
MOD_CK1_1 | 499 | 505 | PF00069 | 0.592 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.459 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.519 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.276 |
MOD_GlcNHglycan | 265 | 268 | PF01048 | 0.350 |
MOD_GlcNHglycan | 310 | 314 | PF01048 | 0.389 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.475 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.397 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.406 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.470 |
MOD_GSK3_1 | 485 | 492 | PF00069 | 0.599 |
MOD_N-GLC_1 | 426 | 431 | PF02516 | 0.275 |
MOD_N-GLC_1 | 432 | 437 | PF02516 | 0.258 |
MOD_N-GLC_2 | 77 | 79 | PF02516 | 0.361 |
MOD_NEK2_1 | 165 | 170 | PF00069 | 0.502 |
MOD_NEK2_1 | 245 | 250 | PF00069 | 0.532 |
MOD_NEK2_1 | 463 | 468 | PF00069 | 0.458 |
MOD_NEK2_1 | 66 | 71 | PF00069 | 0.461 |
MOD_NEK2_2 | 45 | 50 | PF00069 | 0.516 |
MOD_PIKK_1 | 208 | 214 | PF00454 | 0.497 |
MOD_PIKK_1 | 245 | 251 | PF00454 | 0.542 |
MOD_PIKK_1 | 496 | 502 | PF00454 | 0.699 |
MOD_PKA_1 | 55 | 61 | PF00069 | 0.447 |
MOD_Plk_1 | 200 | 206 | PF00069 | 0.491 |
MOD_Plk_1 | 363 | 369 | PF00069 | 0.573 |
MOD_Plk_1 | 432 | 438 | PF00069 | 0.492 |
MOD_Plk_1 | 454 | 460 | PF00069 | 0.497 |
MOD_Plk_1 | 464 | 470 | PF00069 | 0.420 |
MOD_Plk_2-3 | 454 | 460 | PF00069 | 0.460 |
MOD_Plk_4 | 200 | 206 | PF00069 | 0.486 |
MOD_Plk_4 | 366 | 372 | PF00069 | 0.494 |
MOD_Plk_4 | 485 | 491 | PF00069 | 0.415 |
MOD_ProDKin_1 | 32 | 38 | PF00069 | 0.429 |
MOD_ProDKin_1 | 482 | 488 | PF00069 | 0.522 |
MOD_ProDKin_1 | 489 | 495 | PF00069 | 0.584 |
MOD_SUMO_for_1 | 451 | 454 | PF00179 | 0.527 |
MOD_SUMO_for_1 | 82 | 85 | PF00179 | 0.541 |
MOD_SUMO_rev_2 | 112 | 121 | PF00179 | 0.263 |
MOD_SUMO_rev_2 | 228 | 235 | PF00179 | 0.486 |
MOD_SUMO_rev_2 | 94 | 102 | PF00179 | 0.467 |
TRG_DiLeu_BaLyEn_6 | 341 | 346 | PF01217 | 0.545 |
TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.398 |
TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.342 |
TRG_ENDOCYTIC_2 | 132 | 135 | PF00928 | 0.467 |
TRG_ENDOCYTIC_2 | 160 | 163 | PF00928 | 0.483 |
TRG_ENDOCYTIC_2 | 242 | 245 | PF00928 | 0.499 |
TRG_ENDOCYTIC_2 | 277 | 280 | PF00928 | 0.491 |
TRG_ENDOCYTIC_2 | 396 | 399 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 412 | 415 | PF00928 | 0.460 |
TRG_ENDOCYTIC_2 | 460 | 463 | PF00928 | 0.420 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.394 |
TRG_ER_diArg_1 | 348 | 350 | PF00400 | 0.502 |
TRG_Pf-PMV_PEXEL_1 | 61 | 65 | PF00026 | 0.411 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILV0 | Leptomonas seymouri | 79% | 100% |
A0A0S4JLQ2 | Bodo saltans | 59% | 100% |
A0A0S4JPH7 | Bodo saltans | 37% | 80% |
A0A1X0P879 | Trypanosomatidae | 65% | 100% |
A0A1X0P8J8 | Trypanosomatidae | 29% | 100% |
A0A3Q8ID63 | Leishmania donovani | 94% | 100% |
A0A3R7MWC4 | Trypanosoma rangeli | 63% | 100% |
A0A3R7P2U3 | Trypanosoma rangeli | 29% | 100% |
A4HFA0 | Leishmania braziliensis | 88% | 100% |
A4I1M6 | Leishmania infantum | 38% | 98% |
A4I2H5 | Leishmania infantum | 95% | 100% |
C9ZK70 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 67% |
C9ZX10 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 100% |
D0A2I3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AYN7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5B7P8 | Trypanosoma cruzi | 66% | 100% |
V5BHW2 | Trypanosoma cruzi | 37% | 100% |